Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 24, 2020 | Series B | $18M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Paladin Partners Investments | — | Series B |
Norwich Ventures | — | Series B |
Trancos Ventures | — | Series B |